Thrombosis and Hemostasis

SAURABH DAHIYA M.D. currently was working as the Clinical Associate at Bay state Medical Center/Tufts University, Springfield, MA. And also he was Graduate Medical Education Committee, Hematology/Oncology Fellowship Representative. Journal Editorial Board Member for Rare Tumors, Anatomy and physiology: current research, Journal reviewer for Thoracic Cancer and, Journal of Cancer Research and Clinical Oncology, Proposal reviewer- American Geriatrics Society annual meeting. He was Member of American College of Physicians.

Current research: Radioimm unotherapy with Ibritum om ab Tiuxet an Therapy for Patients with Refractory or Relapsed Primary Central Nervous System Lymphoma (PCNSL): a Phase II Trial. Study status – Pre-IRB stages. To examine the barriers to referrals and treatment for Hepatitis C patients in an inner city community. Study status - pas t IRB approval, data collection completed and currently in data analysis phase. Early versus late hospice referrals - a c as e control study. Study status – Manuscript writing in process.

Current researches on Mechanistic study of Wnt components in anthrax toxicity, screening of host targets involved in HCV infection, and Methodological investigation of gene silencing in eukaryotes.

Kenneth K. Wu, M.D., Ph.D... Currently was working as the Distinguished Chair Professor, National Taiwan University College of Medicine, Taiwan. And also he was President, National Health Research Institutes, Taiwan Distinguished Investigator and Acting Director, Cardiovascular and blood Research Center, National Health Research Institutes, Taiwan.

Dr. Wu has a long term interests in two areas of research: (1) Prostaglandin and nitric oxide synthesis and biological activities and (2) Haemostatic and genetic risk of arterial thrombosis. Ongoing research work includes identification and purification of endogenesis factors that central cyclooxygenase-2 (COX-2) expression in proliferating cells, elucidation of mechanisms by which salicylate inhibits transcriptional activation, and the novel actions of prostaglandins on adult cell and embryonic stem cell survival, differentiation and proliferation.

Biochemist, South National University, Bahía Blanca, Argentina Ph.D., Doctor in Chemistry, Thesis: “Role of anti-b2 glycoprotein I and anti-prothrombin autoantibodies in the antiphospholipid syndrome”, University of Buenos Aires, Argentina

Dr. Sridhar Boppana is a Post Doctoral Research Fellow at the Center for Advanced Biotechnology and Medicine (CABM), University of Medicine and Dentistry of New Jersey (UMDNJ. Dr. Sridhar Boppana received his Ph.D degree from Max-Planck Institute for Experimental Medicine, Department of Molecular Biology of Neuronal Signals, George August University, Goettingen, Germany. He has been project assistant in the Institute for Multiple Sclerosis Forschung (IMSF), George August University, Goettingen, Germany in the year 2003-2005. He has done many publications,presentations.

Cancer and Neuroscience, Hematology (B cell lymphoma) and Neurodevelopmental biology (transcriptional gene regulation in the mouse cortex),Neurodegenerative diseases (autoimmune diseases) such as Multiple Sclerosis (MS) and molecular biology techniques.

Sergey Zaets received MD degree from Moscow Medical Institute and PhD and DSc degrees from Bakoulev Center for Cardiovascular Surgery (Moscow, Russia), and used to work as a pediatric cardiac surgeon until relocation to the USA in 1999. During the years 1999-2005, performed research studies on red blood cell dysfunction in trauma-hemorrhagic shock, burn, gut ischemia, and pancreatitis at the UMDNJ - New Jersey Medical School. In 2005, joined Novo Nordisk Inc. Investigated the role of coagulation Factor XIII in prevention of multiple organ dysfunction after experimental trauma-hemorrhagic shock, burn, gut ischemia, and cardio-pulmonary bypass. Since 2009, is involved in clinical development of new recombinant factors to be in hemophilia and FXIII congenital deficiency.

Trauma-hemorrhagic shock, sepsis, coagulation disorders, congenital “open-heart” surgery. Author of more than 200 publications.